---

---

source : Www.biospace.com   

save search

---

Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
Published: 2024-04-16 (Crawled : 00:00) - biospace.com/
EXEL | $22.47 -1.75% -1.78% 2.6M |

Health Technology

| 1.43% | O: -0.62% H: 0.0% C: 0.0%
first financial results

---

AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Published: 2024-04-16 (Crawled : 00:00) - biospace.com/
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -0.22% | O: 0.41% H: 0.0% C: 0.0%
tezspire copd

---

Vizgen Issued a New US Patent for Its MERFISH Technology
Published: 2024-04-16 (Crawled : 18:00) - biospace.com/
TXG | $28.96 -0.69% -0.69% 3M |

Health Technology

| -11.26% | O: -2.62% H: 0.57% C: -3.75%
patent for technology

---

Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
Published: 2024-04-16 (Crawled : 17:00) - biospace.com/
IINN | $1.9 -0.52% 85K |

Manufacturing

| -6.22% | O: 0.0% H: 1.55% C: 0.0%
art100 device for

---

Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Published: 2024-04-16 (Crawled : 16:00) - biospace.com/
BBIO | $24.98 0.0% 2M |

Health Technology

| -3.18% | O: -1.47% H: 2.05% C: -0.59%
nulibry authorization treatment for therapeutics

---

Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
Published: 2024-04-16 (Crawled : 16:00) - biospace.com/
PTPI | $0.69 0.0% 230K |

| -11.89% | O: 9.85% H: 4.63% C: -18.04%
fda positive pharmaceuticals for technology response

---

Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
PPCB | $0.0014 -41.86% 4.4M |

Manufacturing

| -7.14% | O: 0.0% H: 14.29% C: -7.14%
patent cancer biopharma for grant

---

Pelthos Therapeutics Establishes Board of Directors
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -2.29% | O: -0.29% H: 0.0% C: 0.0%
SVRA | $4.81 -3.02% -3.12% 1.2M |

Health Technology

| -4.96% | O: -0.79% H: 6.0% C: 3.2%
INSM | $24.775 -5.37% -5.67% 2.3M |

Health Technology

| -2.39% | O: 0.19% H: 0.41% C: -2.68%
therapeutics

---

Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 0.0% | O: 0.09% H: 0.0% C: 0.0%
announcement conference for financial results

---

Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AMRX | $5.36 -1.83% -1.87% 840K |

Health Technology

| -3.25% | O: -1.08% H: 1.09% C: -0.55%
rtu first

---

VBI Vaccines Reports Full Year 2023 Financial Results
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VBIV | $0.6001 -1.46% -1.48% 180K |

Health Technology

| 8.62% | O: -3.45% H: 14.29% C: 10.71%
year financial results

---

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
NVNO | $4.9 2.08% 2.04% 36K |

Manufacturing

| -2.44% | O: -1.22% H: 0.0% C: -2.06%
symposium topline medical trial

---

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
GIA | $1.08 237.96% 1.4K |

| Email alert Add to watchlist
breast technology trial imaging

---

J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -2.16% | O: -2.09% H: 0.0% C: 0.0%
sales revenue stelara

---

Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K |

Commercial Services

| -1.52% | O: -0.0% H: 0.0% C: -1.52%
animal alternative

---

Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M |

Health Technology

| 51.52% | O: 26.26% H: 73.2% C: 18.87%
health cancer care for commercial

---

RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
RNXT | $1.19 5.07% 5.3K |

| 3.48% | O: -0.87% H: 7.89% C: -0.9%
presentation meeting

---

Radius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
RDUS | $18.72 2.74% 2.67% 280K |

Health Technology

| 6.31% | O: -1.65% H: 0.98% C: 0.69%
osteoarthritis congress world presentation tymlos

---

Scientific Industries Announces Appointment of Industry Leader Michael Blechman as New Board Member
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
SCND | $1.38 0.5% 4.6K |

Manufacturing

| Email alert Add to watchlist

---

Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -0.68% | O: -0.64% H: 0.45% C: -0.04%
million series trials program

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---